Nervgen Pharma NGEN
NASDAQ NGEN
$1.53 -0.01 (-0.66%)
As of: Oct 21, 2026 · 10:21 AM EDT

Nervgen Pharma (NGEN) Research & Development (2025 - 2026)

Updated

Nervgen Pharma (NGEN) posted Research & Development of $5.71 million for the quarter ended Jun 30, 2026, up 191.6% from $1.96 million a year earlier and up 60.9% from the prior quarter.

Analysis

Nervgen Pharma (NGEN) Research & Development (2025 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Research & Development at Nervgen Pharma was $13.4 million; for the year ended Dec 31, 2025, it was $9.95 million, down 13.8% from the prior year.

  • In prior years, Nervgen Pharma's Research & Development was $11.55 million in the year ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Eli Lilly 1,132.34 Bn 1,100.93 Bn 19.71 Bn 3.82 Bn
2 Johnson & Johnson 615.91 Bn 534.44 Bn 17.26 Bn 3.65 Bn
3 AbbVie 505.47 Bn 478.59 Bn 12.70 Bn 2.34 Bn
4 Merck 368.25 Bn 322.63 Bn 12.21 Bn 9.74 Bn
5 Novartis Ag 298.18 Bn 262.17 Bn 11.24 Bn 2.85 Bn
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn 4.05 Bn
7 Amgen 236.22 Bn 191.62 Bn 7.24 Bn 1.87 Bn
8 Gilead Sciences 190.68 Bn 164.87 Bn 6.22 Bn 1.76 Bn
9 Pfizer 170.14 Bn 116.79 Bn 10.94 Bn 2.81 Bn
10 Nervgen Pharma 110.66 Mn 9.54 Mn - 5.71 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.71 Mn
Mar 31, 2026 3.55 Mn
Jun 30, 2025 1.96 Mn
Mar 31, 2025 2.19 Mn
API Access

Nervgen Pharma Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=NGEN&period=max&api_key=YOUR_API_KEY